Literature DB >> 9742467

Effect of L-lactic acid on calcium absorption in rats fed omeprazole.

O Chonan1, R Takahashi, H Yasui, M Watanuki.   

Abstract

We examined the effect of L-lactic acid on calcium absorption in male Wistar rats made achlorhydric by dietary omeprazole, a proton pump inhibitor. The dietary omeprazole intake (0.03 g/100 g of diet) increased the gastric pH and decreased the apparent calcium absorption ratio. Dietary famotidine (0.03 g/100 g of diet), an H2-receptor antagonist, and lower doses of omeprazole (0.005 or 0.01 g/100 g of diet) did not affect the gastric pH or the calcium absorption. In a second experiment, dietary lactic acid (0.5, 1.0, or 2.5 g/100 g of diet) increased the intestinal calcium absorption dose dependently in rats fed omeprazole (0.03 g/100 g of diet). The gastric pH was significantly decreased only in the rats fed higher doses of lactic acid (1.0, or 2.5 g/100 g of diet). In a third experiment, a dietary sour milk beverage containing lactic acid (0.5 g/100 g of diet) increased the intestinal calcium absorption, but did not affect the gastric pH in rats fed omeprazole (0.03 g/100 g of diet). Although the significance of gastric acid in terms of overall calcium absorption is not known, under the present experimental conditions, the inhibition of gastric acid secretion by dietary omeprazole decreased the apparent calcium absorption, and the dietary lactic acid prevented the calcium absorption in rats fed omeprazole.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9742467     DOI: 10.3177/jnsv.44.473

Source DB:  PubMed          Journal:  J Nutr Sci Vitaminol (Tokyo)        ISSN: 0301-4800            Impact factor:   2.000


  17 in total

Review 1.  The risks of PPI therapy.

Authors:  Paul Moayyedi; Grigorios I Leontiadis
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-02-14       Impact factor: 46.802

2.  Use of proton-pump inhibitors and their associated risks among frail elderly nursing home residents.

Authors:  Mariko Teramura-Grönblad; Helka Hosia-Randell; Seija Muurinen; Kaisu Pitkala
Journal:  Scand J Prim Health Care       Date:  2010-09       Impact factor: 2.581

Review 3.  Potential adverse effects of proton pump inhibitors.

Authors:  Gregory A Coté; Colin W Howden
Journal:  Curr Gastroenterol Rep       Date:  2008-06

4.  Hip fracture risk in patients with a diagnosis of pernicious anemia.

Authors:  Nathan A Merriman; Mary E Putt; David C Metz; Yu-Xiao Yang
Journal:  Gastroenterology       Date:  2009-12-21       Impact factor: 22.682

5.  Gastrointestinal hormones/neurotransmitters and growth factors can activate P21 activated kinase 2 in pancreatic acinar cells by novel mechanisms.

Authors:  Bernardo Nuche-Berenguer; R T Jensen
Journal:  Biochim Biophys Acta       Date:  2015-05-12

Review 6.  A benefit-risk assessment of the use of proton pump inhibitors in the elderly.

Authors:  Gwen M C Masclee; Miriam C J M Sturkenboom; Ernst J Kuipers
Journal:  Drugs Aging       Date:  2014-04       Impact factor: 3.923

Review 7.  Chronic proton pump inihibitor therapy and calcium metabolism.

Authors:  Yu-Xiao Yang
Journal:  Curr Gastroenterol Rep       Date:  2012-12

Review 8.  Adverse effects of long-term proton pump inhibitor therapy.

Authors:  Edward Sheen; George Triadafilopoulos
Journal:  Dig Dis Sci       Date:  2011-03-02       Impact factor: 3.199

Review 9.  Association of long-term proton pump inhibitor therapy with bone fractures and effects on absorption of calcium, vitamin B12, iron, and magnesium.

Authors:  Tetsuhide Ito; Robert T Jensen
Journal:  Curr Gastroenterol Rep       Date:  2010-12

10.  Acid-suppressive medications and risk of fracture: an updated meta-analysis.

Authors:  Dawei Cai; Wan Feng; Qing Jiang
Journal:  Int J Clin Exp Med       Date:  2015-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.